Tissue holds more biological information than today’s technologies can fully capture.
Yarra Biosystems is creating an integrated platform for tissue analysis in oncology to capture more of that information, supporting better targets, stronger biomarkers and more informed treatment decisions.
Figure — multiplexed immunofluorescence, representative
Biology read in place, not in isolation.
Tissue behaviour depends on context: which cells are present, where they sit, and how they relate to one another. Yarra Biosystems is working to measure and interpret that context in oncology.
The company is based in Boulder, Colorado, and is developing the platform alongside academic and clinical collaborators.
Target Discovery
Tissue-level patterns that reveal new targets and mechanisms of disease.
Biomarker Development
Biomarkers that better reflect disease biology and therapeutic relevance.
Patient Stratification
Richer tissue insight for defining patient populations and trial hypotheses.
Translational Intelligence
Complex measurements brought together into interpretable biological insight.
The company has taken part in university venture and commercialization programs, broadened its academic and technical network, and is pursuing non-dilutive funding.
Talking with investors, partners, and collaborators.
Investors, strategic partners, academic and technical collaborators, and prospective advisors are all welcome.
Get in touchDesigned for translational oncology.
Yarra Biosystems is developing a tissue-based platform for translational scientists, physician-scientists and clinicians working to identify better targets, develop meaningful biomarkers, stratify patients and make more informed therapeutic decisions.
Target Discovery
Move beyond isolated markers to identify tissue-level biological patterns that can reveal new therapeutic targets and mechanisms of disease.
Biomarker Development
Connect protein expression, spatial organization and biological state to help uncover biomarkers that may better reflect disease biology and therapeutic relevance.
Patient Stratification
Generate richer tissue insight to support translational teams as they define patient populations, refine trial hypotheses and identify those most likely to benefit from a therapy.
Translational Intelligence
Bring complex tissue measurements together into interpretable biological insight for translational scientists, physician-scientists and clinicians working across drug development and clinical research.
Our platform brings together pathology, spatial biology, protein measurement, advanced imaging and an emerging intelligence layer to extract deeper biological information from tissue.
These pages describe the platform at a high level. Component-level and mechanism-level detail is shared with partners under confidentiality.
For a fuller picture, start a conversation.
Contact usA More Complete Picture of Tissue Biology
By connecting protein biology, spatial context and disease state, we aim to uncover biological relationships that can lead to stronger targets, biomarkers and patient stratification strategies.
From Tissue Insight to Therapeutic Decisions
Applications across
Target Validation
Biomarker Development
Cell Therapy
Drug Development
Where pathology meets engineering.
Yarra Biosystems is an early-stage life sciences technology company focused on integrated tissue analysis in oncology. Based in Boulder, Colorado.
Savanh Chantha-Phavong, Ph.D.
Founder, CEO & CSO
Translational Histopathology, Spatial Biology, Digital Pathology, Multiplex Imaging, Tumor Microenvironment
Corey Neu, Ph.D.
Cofounder, Scientific Development
Mechanical and Biomedical Engineering, Cellular Imaging and Mechanobiology
Donnelly Family Endowed Professor, Biomedical Engineering
University of Colorado Boulder
Named for where the journey began.
Yarra Biosystems takes its name from the Yarra River, or Birrarung, in Melbourne, Australia, where our cofounder Savanh Chantha-Phavong’s scientific journey began.
The Birrarung rises in the forested ranges of Victoria, gathering tributaries as it moves through different landscapes and communities before winding through Melbourne and opening into Port Phillip Bay. For the Wurundjeri Woi-wurrung people, the Traditional Owners of much of the land along the Birrarung, the river has long held cultural, ecological and community significance.
That idea of convergence reflects how Yarra Biosystems is being built.
Biology does not happen in isolation. A cell’s behavior is shaped by the proteins it expresses, the signals it receives, the cells around it, and the physical environment of the tissue itself. Tumor, immune and stromal cells continuously influence one another, while proteins translate those interactions into the biological states we observe.
Understanding disease therefore requires more than looking at any one cell, marker or technology alone.
Yarra Biosystems brings together pathology, oncology, spatial biology, engineering, biomaterials and molecular technologies. Just as importantly, we bring together people, ideas, expertise and different ways of thinking.
Like tributaries joining a river, each contributes something different. Together, they create the opportunity to see biology more completely.
Our ambition is to use that convergence to unlock far more information and insight from tissue than has previously been possible, helping uncover new therapeutic targets, clinically meaningful biomarkers, better ways to stratify patients for clinical trials, and ultimately more informed treatment decisions.
Our work now spans continents. Yarra Biosystems is headquartered in Boulder, Colorado, with our cofounder based in the San Francisco Bay Area, while our name remains rooted in Melbourne and the place where it began.
The Birrarung begins in the ranges, gathers strength from what joins it along the way, crosses boundaries and opens toward a much wider horizon.
That is what Yarra Biosystems represents: bringing together the right people, ideas, expertise and technologies to build something capable of revealing far more from tissue than any one approach could alone.
News and announcements.
Announcements will be posted here as the platform develops.
To hear about it first, get in touch.
Contact usLet’s Connect.
We read every message and respond directly. Investors, strategic partners, academic and technical collaborators, and prospective advisors are all welcome.
Message received.
Thank you — we will be in touch shortly.
